| Application no. and date | 21702886.9 (espacenet) (Federated) (European Patent Register), 20210122 | | Patent/reg. no. and date | DK/EP 4093396, 20251210 | | Publication date | 20221130 | | Priority no. and date | US 202062964495 P, 20200122, US 202062964516 P, 20200122, US 202062964507 P, 20200122 | | EP pub. no. and date |
EP 4093396 20221130 | | Effective date | | | Applicant/owner | Bausch Health Ireland Limited, 3013 Lake Drive
Citywest Business Campus
Dublin 24, IE | | Applicant ref. no. | | | Inventor | DESAI, Nayan, c/o Bausch Health 50 Technology Drive
Irvine, California 92618, US,
CHEUNG, Yuk Ying, c/o Bausch Health 50 Technology Drive
Irvine, California 92618, US,
PILLAI, Radhakrishnan, c/o Bausch Health 50 Technology Drive
Irvine, California 92618, US | | Representative | | | Opponent | | | IPC Class | A61K 31/225 (2006.01) , A61K 31/436 (2006.01) , A61K 31/454 (2006.01) , A61K 9/00 (2006.01) , A61K 9/06 (2006.01) , A61P 17/00 (2006.01) , A61P 17/06 (2006.01) | | Title | TOPICAL COMPOSITIONS COMPRISING A MACROLIDE IMMUNOSUPPRESSANT | | Int. application no. | EP2021051478 | | Int. publication no. | WO2021148619 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
